Curtiss-Wright upgraded to Overweight from Equal Weight at Morgan Stanley

Morgan Stanley analyst Kristine Liwag upgraded Curtiss-Wright to Overweight from Equal Weight with a price target of $229, up from $188. The “Pivot to Growth” continues while end market demand remains robust, which positions Curtiss-Wright for “underappreciated topline expansion,” the analyst tells investors. In addition, commercial nuclear optionality and an investor day this upcoming May “could deliver further upside,” the analyst contends.